Search research articles
Contact Us
Filters
Showing results (11-20 of 125) with videos related to
Page
of 13
Sort By:
Journal of Cardiovascular Pharmacology
|
September 1, 1987
Effects of chronic therapy with cilazapril, a new angiotensin-converting enzyme inhibitor, on regional blood flows in conscious spontaneously hypertensive rats
J P Clozel, F Hefti
The American Journal of Physiology
|
June 1, 1993
Hemodynamic variability and circadian rhythm in rats with heart failure: role of locomotor activity
J R Teerlink, J P Clozel
Expert Opinion on Investigational Drugs
|
May 1, 1997
Mibefradil (Ro 40-5967): the first selective T-type Ca2+ channel blocker
S I Ertel, J P Clozel
Bulletin Europeen De Physiopathologie Respiratoire
|
November 1, 1982
[Respiratory insufficiency and pharmacology of theophylline]
J P Clozel, P du Souich
Journal of Hypertension
|
February 1, 1992
A comparison of the effects of renin inhibition and angiotensin converting enzyme inhibition upon bradykinin potentiation
M Véniant, J P Clozel, W Fischli
Journal of Cardiovascular Pharmacology
|
November 1, 1989
Effects of Ro 40-5967, a novel calcium antagonist, on myocardial function during ischemia induced by lowering coronary perfusion pressure in dogs: comparison with verapamil
J P Clozel, L Banken, W Osterrieder
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
August 1, 1996
Telemetry monitoring of pulmonary arterial pressure in freely moving rats
P Hess, M Clozel, J P Clozel
Pharmacology
|
July 1, 1996
Nimodipine does not increase cerebral blood flow during subarachnoid hemorrhage in the rat
H Watanabe, M Clozel, J P Clozel
Cardiovascular Drugs and Therapy
|
June 1, 1990
The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts
J P Clozel, M Véniant, W Osterrieder
Journal of Cardiovascular Pharmacology
|
January 1, 1992
Vascular protection with cilazapril in hypertension
J P Clozel, H Kuhn, F Hefti
Page
of 13
Search research articles
Search
Showing results (11-20 of 125) with videos related to
Sort By:
Page
of 13
Journal of Cardiovascular Pharmacology
|
September 1, 1987
Effects of chronic therapy with cilazapril, a new angiotensin-converting enzyme inhibitor, on regional blood flows in conscious spontaneously hypertensive rats
J P Clozel, F Hefti
The American Journal of Physiology
|
June 1, 1993
Hemodynamic variability and circadian rhythm in rats with heart failure: role of locomotor activity
J R Teerlink, J P Clozel
Expert Opinion on Investigational Drugs
|
May 1, 1997
Mibefradil (Ro 40-5967): the first selective T-type Ca2+ channel blocker
S I Ertel, J P Clozel
Bulletin Europeen De Physiopathologie Respiratoire
|
November 1, 1982
[Respiratory insufficiency and pharmacology of theophylline]
J P Clozel, P du Souich
Journal of Hypertension
|
February 1, 1992
A comparison of the effects of renin inhibition and angiotensin converting enzyme inhibition upon bradykinin potentiation
M Véniant, J P Clozel, W Fischli
Journal of Cardiovascular Pharmacology
|
November 1, 1989
Effects of Ro 40-5967, a novel calcium antagonist, on myocardial function during ischemia induced by lowering coronary perfusion pressure in dogs: comparison with verapamil
J P Clozel, L Banken, W Osterrieder
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
August 1, 1996
Telemetry monitoring of pulmonary arterial pressure in freely moving rats
P Hess, M Clozel, J P Clozel
Pharmacology
|
July 1, 1996
Nimodipine does not increase cerebral blood flow during subarachnoid hemorrhage in the rat
H Watanabe, M Clozel, J P Clozel
Cardiovascular Drugs and Therapy
|
June 1, 1990
The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts
J P Clozel, M Véniant, W Osterrieder
Journal of Cardiovascular Pharmacology
|
January 1, 1992
Vascular protection with cilazapril in hypertension
J P Clozel, H Kuhn, F Hefti
Page
of 13